REGENXBIO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.44 USD | -1.53% |
|
-8.26% | -13.98% |
| May. 09 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
| May. 08 | Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 18.30 | 24.61 | 22.75 |
| Spread/Res. | -15.63% | -37.26% | -32.13% |
| Spread/Supp. | +0.59% | +26.87% | +26.14% |
| Support | 15.35 | 12.17 | 12.24 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- RGNX Stock
- Charts REGENXBIO Inc.
